Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Hookipa Pharma Inc
(NQ:
HOOK
)
5.100
-0.110 (-2.11%)
Streaming Delayed Price
Updated: 12:14 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Hookipa Pharma Inc
< Previous
1
2
3
4
5
6
7
8
Next >
HOOKIPA Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
September 12, 2023
From
HOOKIPA Pharma Inc.
Via
GlobeNewswire
7 Biotech Stocks to Sell in September Before They Crash & Burn
September 06, 2023
These are just a few of the top biotech stocks to sell today - especially with each of the firms dealing with legitimate issues.
Via
InvestorPlace
HOOKIPA Pharma to participate in upcoming investor conferences in September
September 06, 2023
From
HOOKIPA Pharma Inc.
Via
GlobeNewswire
What 4 Analyst Ratings Have To Say About HOOKIPA Pharma
June 05, 2023
Via
Benzinga
Recap: HOOKIPA Pharma Q1 Earnings
May 11, 2023
Via
Benzinga
Earnings Outlook For HOOKIPA Pharma
May 10, 2023
Via
Benzinga
Looking Into HOOKIPA Pharma's Return On Capital Employed
March 16, 2023
Via
Benzinga
HOOKIPA Pharma Reports Second Quarter 2023 Financial Results and Recent Business Highlights
August 10, 2023
From
HOOKIPA Pharma Inc.
Via
GlobeNewswire
HOOKIPA Pharma to Report Second Quarter 2023 Financial Results and Recent Business Highlights on August 10, 2023
August 03, 2023
From
HOOKIPA Pharma Inc.
Via
GlobeNewswire
1847 Holdings And 3 Other Stocks Under $1 Insiders Are Buying
July 12, 2023
The Dow Jones closed higher by over 300 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...
Via
Benzinga
TeraWulf And 3 Other Stocks Under $3 Insiders Are Aggressively Buying
July 10, 2023
The Dow Jones closed lower by over 180 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested...
Via
Benzinga
HOOKIPA Pharma's Earnings Outlook
March 14, 2023
Via
Benzinga
CURO Group And 2 Other Stocks Under $3 Insiders Are Aggressively Buying
July 06, 2023
The Dow Jones closed lower by over 100 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...
Via
Benzinga
HOOKIPA Pharma And 3 Other Stocks Under $2 Insiders Are Aggressively Buying
July 05, 2023
The Dow Jones closed slightly higher on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
June 13, 2023
Via
Benzinga
HOOKIPA Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
June 10, 2023
From
HOOKIPA Pharma Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's Intraday Session
June 01, 2023
Via
Benzinga
HOOKIPA Pharma Announces Pricing of $50.0 Million Public Offering of Common Stock and Non-Voting Convertible Preferred Stock
May 31, 2023
From
HOOKIPA Pharma Inc.
Via
GlobeNewswire
HOOKIPA Pharma Announces Positive Preliminary Phase 2 Data on HB-200 in Combination with Pembrolizumab in Patients with HPV16+ Head and Neck Cancers
May 31, 2023
From
HOOKIPA Pharma Inc.
Via
GlobeNewswire
HOOKIPA Pharma Reports First Quarter 2023 Financial Results and Recent Business Highlights
May 11, 2023
From
HOOKIPA Pharma Inc.
Via
GlobeNewswire
HOOKIPA Announces First Person Dosed in Phase 1a/b Clinical Trial of HB-400, in Collaboration with Gilead, for Treatment of Hepatitis B
May 09, 2023
From
HOOKIPA Pharma Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's Intraday Session
May 05, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
May 04, 2023
Via
Benzinga
HOOKIPA Pharma to Participate in Upcoming Investor Conferences in May
May 04, 2023
From
HOOKIPA Pharma Inc.
Via
GlobeNewswire
HOOKIPA Pharma to Report First Quarter 2023 Financial Results and Recent Business Highlights on May 11, 2023
May 04, 2023
From
HOOKIPA Pharma Inc.
Via
GlobeNewswire
HOOKIPA to Present a Trial in Progress Poster on its Prostate Cancer Phase 1/2 Clinical Trial at ASCO
April 26, 2023
From
HOOKIPA Pharma Inc.
Via
GlobeNewswire
HOOKIPA Pharma to Participate in the Van Lanschot Kempen Life Sciences Conference
April 19, 2023
From
HOOKIPA Pharma Inc.
Via
GlobeNewswire
HOOKIPA Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
April 14, 2023
From
HOOKIPA Pharma Inc.
Via
GlobeNewswire
HOOKIPA Reports Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Outlook
March 15, 2023
From
HOOKIPA Pharma Inc.
Via
GlobeNewswire
Earnings Scheduled For March 15, 2023
March 15, 2023
Companies Reporting Before The Bell • Sportradar Gr (NASDAQ:SRAD) is estimated to report quarterly earnings at $0.04 per share on revenue of $208.09 million.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.